Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

DDX39 acts as a suppressor of invasion for bladder cancer.

Kato M, Wei M, Yamano S, Kakehashi A, Tamada S, Nakatani T, Wanibuchi H.

Cancer Sci. 2012 Jul;103(7):1363-9. doi: 10.1111/j.1349-7006.2012.02298.x. Epub 2012 Jun 4.

PMID:
22494014
[PubMed - indexed for MEDLINE]
2.

An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.

Dickinson AJ, Fox SB, Newcomb PV, Persad RA, Sibley GN, Harris AL.

J Urol. 1995 Jul;154(1):237-41.

PMID:
7776437
[PubMed - indexed for MEDLINE]
3.

Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas.

Ohlsson G, Moreira JM, Gromov P, Sauter G, Celis JE.

Mol Cell Proteomics. 2005 Apr;4(4):570-81. Epub 2005 Feb 25.

PMID:
15734831
[PubMed - indexed for MEDLINE]
Free Article
4.

Expression of Bmi-1 is a prognostic marker in bladder cancer.

Qin ZK, Yang JA, Ye YL, Zhang X, Xu LH, Zhou FJ, Han H, Liu ZW, Song LB, Zeng MS.

BMC Cancer. 2009 Feb 19;9:61. doi: 10.1186/1471-2407-9-61.

PMID:
19228380
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors.

Lascombe I, Clairotte A, Fauconnet S, Bernardini S, Wallerand H, Kantelip B, Bittard H.

Clin Cancer Res. 2006 May 1;12(9):2780-7.

PMID:
16675571
[PubMed - indexed for MEDLINE]
Free Article
6.

Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder.

Wild PJ, Herr A, Wissmann C, Stoehr R, Rosenthal A, Zaak D, Simon R, Knuechel R, Pilarsky C, Hartmann A.

Clin Cancer Res. 2005 Jun 15;11(12):4415-29.

PMID:
15958626
[PubMed - indexed for MEDLINE]
Free Article
7.

Expression analysis of VEGF-A and VEGF-B: relationship with clinicopathological parameters in bladder cancer.

Fauconnet S, Bernardini S, Lascombe I, Boiteux G, Clairotte A, Monnien F, Chabannes E, Bittard H.

Oncol Rep. 2009 Jun;21(6):1495-504.

PMID:
19424629
[PubMed - indexed for MEDLINE]
8.

Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.

Friedrich MG, Toma MI, Petri S, Cheng JC, Hammerer P, Erbersdobler A, Huland H.

Eur Urol. 2004 Jun;45(6):737-43.

PMID:
15149745
[PubMed - indexed for MEDLINE]
9.

Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome.

Sgambato A, Migaldi M, Faraglia B, De Aloysio G, Ferrari P, Ardito R, De Gaetani C, Capelli G, Cittadini A, Trentini GP.

Int J Cancer. 2002 Feb 10;97(5):671-8.

PMID:
11807796
[PubMed - indexed for MEDLINE]
10.

Association of TSC1/hamartin, 14-3-3sigma, and p27 expression with tumor outcomes in patients with pTa/pT1 urothelial bladder carcinoma.

Mhawech-Fauceglia P, Alvarez V, Fischer G, Beck A, Herrmann FR.

Am J Clin Pathol. 2008 Jun;129(6):918-23. doi: 10.1309/D81QMXPMC3QHT57Y.

PMID:
18480009
[PubMed - indexed for MEDLINE]
Free Article
11.

Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma.

Tsui KH, Cheng AJ, Chang Pe, Pan TL, Yung BY.

Urology. 2004 Oct;64(4):839-44.

PMID:
15491744
[PubMed - indexed for MEDLINE]
12.

Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer.

Kim EJ, Lee YS, Kim YJ, Kim MJ, Ha YS, Jeong P, Lee OJ, Kim WJ.

Urology. 2010 Jun;75(6):1516.e9-13. doi: 10.1016/j.urology.2009.08.055. Epub 2009 Nov 13.

PMID:
19913893
[PubMed - indexed for MEDLINE]
13.

Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma.

Su JS, Arima K, Hasegawa M, Franco OE, Umeda Y, Yanagawa M, Sugimura Y, Kawamura J.

Int J Urol. 2004 Feb;11(2):74-82.

PMID:
14706010
[PubMed - indexed for MEDLINE]
14.

Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells.

Kim CJ, Yoshioka N, Tambe Y, Kushima R, Okada Y, Inoue H.

Int J Cancer. 2005 Oct 20;117(1):51-8.

PMID:
15880581
[PubMed - indexed for MEDLINE]
15.

The nucleosome binding protein NSBP1 is highly expressed in human bladder cancer and promotes the proliferation and invasion of bladder cancer cells.

Wahafu W, He ZS, Zhang XY, Zhang CJ, Yao K, Hao H, Song G, He Q, Li XS, Zhou LQ.

Tumour Biol. 2011 Oct;32(5):931-9. doi: 10.1007/s13277-011-0195-0. Epub 2011 Jun 22.

PMID:
21695596
[PubMed - indexed for MEDLINE]
16.

RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer.

Yan C, Kim YW, Ha YS, Kim IY, Kim YJ, Yun SJ, Moon SK, Bae SC, Kim WJ.

J Surg Oncol. 2012 Mar 15;105(4):425-30. doi: 10.1002/jso.22087. Epub 2011 Aug 30.

PMID:
22311819
[PubMed - indexed for MEDLINE]
17.

Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcome.

He HC, Chen JH, Chen XB, Qin GQ, Cai C, Liang YX, Han ZD, Dai QS, Chen YR, Zeng GH, Zhu JG, Jiang FN, Zhong WD.

Pathol Oncol Res. 2012 Apr;18(2):349-55. doi: 10.1007/s12253-011-9451-2. Epub 2011 Aug 24.

PMID:
21861243
[PubMed - indexed for MEDLINE]
18.

Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer.

Yamamoto Y, Matsuyama H, Furuya T, Oga A, Yoshihiro S, Okuda M, Kawauchi S, Sasaki K, Naito K.

Clin Cancer Res. 2004 Oct 1;10(19):6449-55.

PMID:
15475431
[PubMed - indexed for MEDLINE]
Free Article
19.

Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.

Garg M, Kanojia D, Seth A, Kumar R, Gupta A, Surolia A, Suri A.

Eur J Cancer. 2010 Jan;46(1):207-15. doi: 10.1016/j.ejca.2009.10.020. Epub .

PMID:
19914824
[PubMed - indexed for MEDLINE]
20.

FGFR3 mutational status and protein expression in patients with bladder cancer in a Jordanian population.

Bodoor K, Ghabkari A, Jaradat Z, Alkhateeb A, Jaradat S, Al-Ghazo MA, Matalka I, Musleh H, Haddad Y.

Cancer Epidemiol. 2010 Dec;34(6):724-32. doi: 10.1016/j.canep.2010.05.003. Epub 2010 Jun 9.

PMID:
20542753
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk